Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial
Yigit E, Unsal S
Published in Climacteric
Methodology
Prospective randomized placebo-controlled trial of red clover isoflavones in postmenopausal women with dyslipidemia, assessing Menopause Rating Scale and lipid profile at 3 and 6 months.
Key Findings
Menopause Rating Scale scores and total cholesterol, LDL-C and triglycerides fell significantly with red clover; HDL-C rose, with most between-group differences favoring treatment.
Conclusions
Red clover isoflavones over 3-6 months improved menopausal symptoms and lipids in this trial.
Limitations
Single-center trial, limited sample, no long-term safety data.
Supplements Studied
Red clover treatment for 3-6 months demonstrated significant improvements in lipid profiles and menopausal symptoms.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.